Lourdes Prieto

Lourdes Prieto

Auto-generated profile, based on publicly available information

Lourdes Prieto

Nicklaus Children's Hospital, Miami, Florida, USA

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2021 in Circulation: Cardiovascular Interventions
Verified
Journal Article
Closed access
PDF file
SGSrinath T. Gowda
Srinath T. Gowda
LLLarry Latson
Larry Latson
KSKothandam Sivakumar
Kothandam Sivakumar
GHGurumurthy Hiremath
Gurumurthy Hiremath
MCMatthew Crystal
Matthew Crystal
AQAthar Qureshi
Athar Qureshi
Background: Coronary artery fistulas (CAFs) presenting in infancy are rare, and data regarding postclosure sequelae and follow-up are limited. Methods: A retrospective review of all the neonates and infants (<1 year) was conducted from the CAF registry for CAF treatment. The CAF type (proximal or distal), size, treatment method, and follow-up angiography were reviewed to assess outcomes and coronary remodeling. Results: Forty-eight patients were included from 20 centers. Of these, 30 were proximal and 18 had distal CAF; 39 were large, 7 medium, and 2 had small CAF. The median age and weight was 0.16 years (0.01–1) and 4.2 kg (1.7–10.6). Heart failure was noted in 28 of 48 (58%) patients. Transcatheter closure was performed in 24, surgical closure in 18, and 6 were observed medically. Procedural success was 92% and 94 % for transcatheter closure and surgical closure, respectively. Follow-up data were obtained in 34 of 48 (70%) at a median of 2.9 (0.1–18) years. Angiography to assess remodeling was available in 20 of 48 (41%). I. Optimal remodeling (n=10, 7 proximal and 3 distal CAF). II. Suboptimal remodeling (n=7) included (A) symptomatic coronary thrombosis (n=2, distal CAF), (B) asymptomatic coronary thrombosis (n=3, 1 proximal and 2 distal CAF), and (C) partial thrombosis with residual cul-de-sac (n=1, proximal CAF) and vessel irregularity with stenosis (n=1, distal CAF). Finally, (III) persistent coronary artery dilation (n=4). Antiplatelets and anticoagulation were used in 31 and 7 patients post-closure, respectively. Overall, 7 of 10 (70%) with proximal CAF had optimal remodeling, but 5 of 11 (45%) with distal CAF had suboptimal remodeling. Only 1 of 7 patients with suboptimal remodeling were on anticoagulation. Conclusions: Neonates/infants with hemodynamically significant CAF can be treated by transcatheter or surgical closure with excellent procedural success. Patients with distal CAF are at higher risk for suboptimal remodeling. Postclosure anticoagulation and follow-up coronary anatomic evaluation are warranted.

29 June 2012 in Journal of Child Neurology
Verified
Journal Article
Closed access
PDF file
AMAhsan Moosa
Ahsan Moosa
ETElias I. Traboulsi
Elias I. Traboulsi
JRJanet Reid
Janet Reid
LPLourdes Prieto
Lourdes Prieto
RMRocio Moran
Rocio Moran
NFNeil R. Friedman
Neil R. Friedman
Mutations in the smooth muscle–specific isoform of α-actin (ACTA2) cause vascular smooth muscle dysfunction leading to aortic aneurysm and moyamoya syndrome. A unique R179H mutation in ACTA2 has been reported to result in widespread smooth muscle dysfunction affecting vascular and extravascular smooth muscles. We report a 7-year-old girl with an ACTA2 R179H mutation manifesting with neonatal seizures due to multifocal infarcts, asymmetric motor deficits, global developmental delay, spasticity, congenital bilateral mydriasis, and a large patent ductus arteriosus. Serial magnetic resonance imaging (MRI) of the brain over 7 years showed diffuse supratentorial white matter abnormalities consistent with a progressive leukoencephalopathy. Magnetic resonance angiography of the cerebral vessels showed stenosis in the terminal portion of the bilateral internal carotid arteries with fusiform dilation of the proximal segment. Neonatal onset of neurologic symptoms in ACTA2 mutations has not been previously reported. R179H mutation in ACTA2 represents the severe end of the disease spectrum.

3 October 2020 in Current Cardiology Reports
Verified
Journal Article
Closed access
PDF file
PSPatcharapong Suntharos
Patcharapong Suntharos
LPLourdes R. Prieto
Lourdes R. Prieto

1 April 2018 in JACC: Cardiovascular Interventions
Verified
Journal Article
Closed access
LPLourdes R. Prieto
Lourdes R. Prieto

1 June 2021 in JACC
Verified
Journal Article
Closed access
LPLourdes R. Prieto
Lourdes R. Prieto

11 January 2022 in Catheterization and Cardiovascular Interventions
Verified
Journal Article
Open access
PDF file
LALiliam Aquino
Liliam Aquino
JMJuan Carlos Muniz
Juan Carlos Muniz
PLPablo Marcelo Laufer
Pablo Marcelo Laufer
LPLourdes R. Prieto
Lourdes R. Prieto
Device‐related thrombosis and device‐related endocarditis after atrial septal defect (ASD) transcatheter closure are extremely rare. It is known that COVID‐19 infection could lead to a thrombotic microangiopathy‐like phenomenon. We present the case of a 14‐year‐old female who developed fever and was found to have a thrombus on the right atrial side of the ASD closure device weeks after an asymptomatic COVID‐19 infection and negative COVID‐19 test 2 days before transcatheter ASD closure. Although there is no certainty that the thrombus was related to the prior COVID‐19 infection, the possibility of an ongoing COVID‐19‐related hypercoagulable state should be entertained.